Outcomes of Intermediate Risk Non–muscle-invasive Bladder Cancer Receiving Adjuvant Treatment: A Pooled Analysis of Four Randomized Controlled Trials

Study limitation reported by the research below: “Sex distribution of the cohort is not reported in the abstract; 'mixed' is assumed based on typical bladder cancer trial populations.”